PortfoliosLab logo
Angelalign Technology Inc (6699.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG0405D1051

Highlights

Market Cap

HK$9.00B

PE Ratio

96.27

Year Range

HK$45.75 - HK$79.80

Target Price

HK$79.76

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

Angelalign Technology Inc (6699.HK) returned -9.87% year-to-date (YTD) and -28.59% over the past 12 months.


6699.HK

YTD

-9.87%

1M

9.29%

6M

-18.41%

1Y

-28.59%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.77%

1M

7.44%

6M

-5.60%

1Y

8.37%

5Y*

14.12%

10Y*

10.46%

*Annualized

Monthly Returns

The table below presents the monthly returns of 6699.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-7.06%13.00%-10.45%-11.95%8.84%-9.87%
2024-5.92%23.59%14.37%5.05%-22.47%-7.35%-3.74%2.24%37.65%-19.14%2.87%-6.45%5.78%
2023-12.68%0.19%8.46%-16.07%-25.88%0.62%8.54%-33.42%-6.98%10.59%14.59%-8.27%-53.59%
2022-33.88%13.64%-28.07%-16.91%20.57%17.58%-9.73%-2.89%-45.32%-8.03%39.47%27.26%-50.19%
2021-0.10%3.59%-6.99%-13.99%-3.92%10.85%-29.47%-37.81%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 6699.HK is 22, meaning it’s performing worse than 78% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 6699.HK is 2222
Overall Rank
The Sharpe Ratio Rank of 6699.HK is 1616
Sharpe Ratio Rank
The Sortino Ratio Rank of 6699.HK is 2020
Sortino Ratio Rank
The Omega Ratio Rank of 6699.HK is 2222
Omega Ratio Rank
The Calmar Ratio Rank of 6699.HK is 3131
Calmar Ratio Rank
The Martin Ratio Rank of 6699.HK is 2222
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Angelalign Technology Inc (6699.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Angelalign Technology Inc Sharpe ratios as of May 11, 2025 (values are recalculated daily):

  • 1-Year: -0.65
  • All Time: -0.65

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Angelalign Technology Inc compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History

Angelalign Technology Inc provided a 2.08% dividend yield over the last twelve months, with an annual payout of HK$1.10 per share.


1.00%1.20%1.40%1.60%1.80%HK$0.00HK$0.20HK$0.40HK$0.60HK$0.80HK$1.00HK$1.20202220232024
Dividends
Dividend Yield
PeriodTTM202420232022
DividendHK$1.10HK$1.10HK$0.68HK$1.22

Dividend yield

2.08%1.87%1.20%0.99%

Monthly Dividends

The table displays the monthly dividend distributions for Angelalign Technology Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2024HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$1.10HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$1.10
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.68HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.68
2022HK$1.22HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$1.22

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Angelalign Technology Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Angelalign Technology Inc was 90.00%, occurring on Oct 5, 2023. The portfolio has not yet recovered.

The current Angelalign Technology Inc drawdown is 88.08%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90%Jul 26, 2021541Oct 5, 2023
-11.41%Jun 23, 202110Jul 7, 20218Jul 19, 202118
-5.24%Jun 17, 20211Jun 17, 20213Jun 22, 20214

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Angelalign Technology Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Angelalign Technology Inc is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for 6699.HK, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, 6699.HK has a P/E ratio of 96.3. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for 6699.HK relative to other companies in the Medical Instruments & Supplies industry. Currently, 6699.HK has a P/S ratio of 33.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for 6699.HK in comparison with other companies in the Medical Instruments & Supplies industry. Currently, 6699.HK has a P/B value of 2.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items